Literature DB >> 18292358

Clinical trial design in fracture-healing research: meeting the challenge.

Saam Morshed1, Mohit Bhandari.   

Abstract

The rapidly growing global burden of road-traffic accidents and fragility fractures makes research on fracture repair a vital component of the efforts needed to face this rising public health challenge. The focus on developing new and innovative strategies to treat fractures is easily justifiable given the potential human benefit from such discoveries. Randomized trials remain the standard to which the evaluation of novel fracture-healing therapies must continue to evolve. This article reviews randomized controlled trials in the context of the hierarchy of evidence, special challenges to their conduct in the setting of surgical research, and lessons learned from fracture-healing trials published to date. Suggestions are made regarding the optimal characteristics of fracture models and logistical consideration for ensuring the success of future trials. The realization that surgical trials have unique methodological and interpretative challenges has fueled a renewed vision of the design and execution of large, definitive clinical trials with a meaningful impact on the lives of patients.

Entities:  

Mesh:

Year:  2008        PMID: 18292358     DOI: 10.2106/JBJS.G.01478

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  7 in total

1.  Challenges for Large Orthopaedic Hospitals Worldwide-An ISOC Position Statement.

Authors:  Patrick S Sussmann; Beat R Simmen; Joerg Goldhahn; Thomas P Sculco
Journal:  HSS J       Date:  2009-12-11

2.  Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 Weeks.

Authors:  Per Aspenberg; Jorge Malouf; Umberto Tarantino; Pedro A García-Hernández; Costantino Corradini; Søren Overgaard; Jan J Stepan; Lars Borris; Eric Lespessailles; Frede Frihagen; Kyriakos Papavasiliou; Helmut Petto; José Ramón Caeiro; Fernando Marin
Journal:  J Bone Joint Surg Am       Date:  2016-11-16       Impact factor: 5.284

3.  Are large fracture trials really possible? What we have learned from the randomized controlled damage control study?

Authors:  Eva Steinhausen; Bertil Bouillon; Dieter Rixen
Journal:  Eur J Trauma Emerg Surg       Date:  2017-12-28       Impact factor: 3.693

Review 4.  Resolving controversies in hip fracture care: the need for large collaborative trials in hip fractures.

Authors:  Mohit Bhandari; Sheila Sprague; Emil H Schemitsch
Journal:  J Orthop Trauma       Date:  2009-07       Impact factor: 2.512

5.  Angiogenic conditioning of peripheral blood mononuclear cells promotes fracture healing.

Authors:  K Mifuji; M Ishikawa; N Kamei; R Tanaka; K Arita; H Mizuno; T Asahara; N Adachi; M Ochi
Journal:  Bone Joint Res       Date:  2017-08       Impact factor: 5.853

6.  Autologous bone grafts with MSCs or FGF-2 accelerate bone union in large bone defects.

Authors:  Hiroaki Murakami; Tomoyuki Nakasa; Masakazu Ishikawa; Nobuo Adachi; Mitsuo Ochi
Journal:  J Orthop Surg Res       Date:  2016-09-26       Impact factor: 2.359

Review 7.  Biologic adjuvants for fracture healing.

Authors:  Mandeep S Virk; Jay R Lieberman
Journal:  Arthritis Res Ther       Date:  2012-11-30       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.